Use and outcomes of hepatitis B virus–positive grafts in orthotopic liver transplantation in the United States from 1999 to 2021
Saad Emhmed Ali, Philip Vutien, C. Andrew Bonham, Charles Landis, Paul Kwo, Carlos Esquivel, Mindie H. Nguyen – 16 July 2022 – The demand for orthotopic liver transplantation (OLT) is projected to increase, which indicates a need to expand the liver donor pool. We aimed to investigate the use of hepatitis B virus (HBV)–positive grafts and the outcomes of recipients undergoing OLT with HBV‐positive grafts.